Browse Category

NASDAQ:IBRX.O News 20 January 2026

ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing

ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing

New York, January 20, 2026, 08:14 (EST) — Premarket ImmunityBio (IBRX.O) shares rose about 27% to $7 in premarket trading on Tuesday, with about 4.1 million shares changing hands, after the company said it had made progress with the U.S. Food and Drug Administration on a path to revive a label-expansion push for its bladder cancer treatment ANKTIVA. (Public) The…

Stock Market Today

  • Marsh & McLennan Companies Shares Yield Tops 2% Amid Dividend Focus
    January 23, 2026, 3:45 PM EST. Shares of Marsh & McLennan Companies Inc (MRSH) traded at yields exceeding 2% on Friday, based on an annualized dividend of $3.60 and a stock price as low as $178.00. Dividends have historically contributed significantly to total stock market returns. For example, S&P 500 ETF investors from 1999 to 2012 saw a modest price loss offset by substantial dividend income, resulting in a positive total return. While dividends reflect company profitability and can vary, MRSH's place in the S&P 500 underscores its large-cap status. Investors evaluating the sustainability of the 2% yield should consider the company's dividend history and profitability trends.
Go toTop